Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.38 |
| ▸ | RAB9A | P51151 | 1/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9109791 | 1.00 | NPC1 (0.38) | NPC1RAB9AALDH1A1SMN1; SMN2MEN1 | |
| SCHEMBL6158534 | 0.86 | — | — | |
| SCHEMBL9113677 | 0.86 | — | — | |
| SCHEMBL9111784 | 0.79 | NPC1 (0.41) | NPC1RAB9AALDH1A1SMN1; SMN2 | |
| SCHEMBL9111774 | 0.79 | NPC1 (0.41) | NPC1RAB9AALDH1A1SMN1; SMN2 | |
| SCHEMBL12179448 | 0.76 | — | — | |
| SCHEMBL9111892 | 0.76 | NPC1 (0.39) | NPC1RAB9AALDH1A1SMN1; SMN2 | |
| SCHEMBL8484837 | 0.74 | — | — | |
| SCHEMBL370487 | 0.73 | NPC1 (0.40) | NPC1RAB9AALDH1A1SMN1; SMN2 | |
| SCHEMBL9110307 | 0.73 | NPC1 (0.37) | NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0670831-A1 | QUINOXALINE DERIVATIVE AS ANTIDIABETIC AGENT | OTSUKA PHARMACEUTICAL CO., LTD. (JP) | 1995-09-13 | — | — | EP | disclosed |
| WO-1995009159-A1 | QUINOXALINE DERIVATIVE AS ANTIDIABETIC AGENT | OTSUKA PHARMACEUTICAL COMPANY, LIMITED (JP) | 1995-04-06 | — | — | WO | disclosed |